Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria (Q33890750)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria |
scientific article |
Statements
1 reference
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria (English)
1 reference
Michael A Pfaller
1 reference
Ana Espinel-Ingroff
1 reference
Thomas J Walsh
1 reference
Luis Ostrosky-Zeichner
1 reference
David Andes
1 reference
Maiken C Arendrup
1 reference
Barbara D Alexander
1 reference
Steven D Brown
1 reference
Vishnu Chaturvedi
1 reference
Cynthia L Fowler
1 reference
Mahmoud A Ghannoum
1 reference
Elizabeth M Johnson
1 reference
Cynthia C Knapp
1 reference
Mary R Motyl
1 reference
1 reference
Identifiers
1 reference